Compound: Cabozantinib

Drug Target: VEGFR, MET, RET, KIT, FLT1, FLT3, FLT4, TIE2,AXL

Drug Target pathway: RTK signaling

Dataset


Tissue specific analysis

Contact us | Cookies policy | Terms & Conditions. This site is hosted by the Wellcome Sanger Institute.